Alexander Bastian

Alexander Bastian is a seasoned professional in commercial strategy and business development within the pharmaceutical industry, currently serving as Vice President at Memo Therapeutics AG since September 2024. With significant experience gained through leadership roles at AM-Pharma, Galapagos, and Incyte, Bastian has demonstrated expertise in building teams and developing pricing, market access, and health economics strategies. Previous positions include Vice President at GfK Bridgehead, where Bastian contributed to market access strategies for global clients, and a range of roles at Pfizer and Amgen. Educational background includes an MBA from IESE Business School, a Bachelor's degree from the University of Minnesota, and ongoing doctoral studies in Health Policy & Management at Johns Hopkins Bloomberg School of Public Health. Disease expertise spans oncology, respiratory conditions, diabetes, cardiovascular diseases, and more.